Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian G Pierce

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Journal of Molecular Biology|August 2, 2015
Updates to the Integrated Protein-Protein Interaction Benchmarks: Docking Benchmark Version 5 and Affinity Benchmark Version 2Thom Vreven, Iain H Moal, Anna Vangone, et al.
Nature Communications|December 15, 2023
A single C-terminal residue controls SARS-CoV-2 spike trafficking and incorporation into VLPsDebajit Dey, Enya Qing, Yanan He, et al.
Science Advances|April 10, 2024
Combinatorially restricted computational design of protein-protein interfaces to produce IgG heterodimersTala Azzam, Jonathan J Du, Maria W Flowers, et al.
Genome Research|September 8, 2012
Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factorsJie Wang, Jiali Zhuang, Sowmya Iyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2022
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidateRuixue Wang, Saori Suzuki, Johnathan D Guest, et al.
The Journal of General Virology|January 13, 2026
Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independentJessica L Mimms, Ariadne Sinnis-Bourozikas, Nathaniel R Felbinger, et al.
Journal of Virology|January 18, 2019
Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect CellsRichard A Urbanowicz, Ruixue Wang, John E Schiel, et al.
Plos Pathogens|May 18, 2019
Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine designZhen-Yong Keck, Brian G Pierce, Patrick Lau, et al.
Journal of Virology|September 4, 2020
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-NeutralizationBrian G Pierce, Zhen-Yong Keck, Ruixue Wang, et al.
Hepatology (Baltimore, Md.)|September 20, 2016
Affinity maturation of a broadly neutralizing human monoclonal antibody that prevents acute hepatitis C virus infection in miceZhen-Yong Keck, Yong Wang, Patrick Lau, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Journal of Molecular Biology|August 2, 2015
Updates to the Integrated Protein-Protein Interaction Benchmarks: Docking Benchmark Version 5 and Affinity Benchmark Version 2Thom Vreven, Iain H Moal, Anna Vangone, et al.
Nature Communications|December 15, 2023
A single C-terminal residue controls SARS-CoV-2 spike trafficking and incorporation into VLPsDebajit Dey, Enya Qing, Yanan He, et al.
Science Advances|April 10, 2024
Combinatorially restricted computational design of protein-protein interfaces to produce IgG heterodimersTala Azzam, Jonathan J Du, Maria W Flowers, et al.
Genome Research|September 8, 2012
Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factorsJie Wang, Jiali Zhuang, Sowmya Iyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2022
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidateRuixue Wang, Saori Suzuki, Johnathan D Guest, et al.
The Journal of General Virology|January 13, 2026
Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independentJessica L Mimms, Ariadne Sinnis-Bourozikas, Nathaniel R Felbinger, et al.
Journal of Virology|January 18, 2019
Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect CellsRichard A Urbanowicz, Ruixue Wang, John E Schiel, et al.
Plos Pathogens|May 18, 2019
Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine designZhen-Yong Keck, Brian G Pierce, Patrick Lau, et al.
Journal of Virology|September 4, 2020
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-NeutralizationBrian G Pierce, Zhen-Yong Keck, Ruixue Wang, et al.
Hepatology (Baltimore, Md.)|September 20, 2016
Affinity maturation of a broadly neutralizing human monoclonal antibody that prevents acute hepatitis C virus infection in miceZhen-Yong Keck, Yong Wang, Patrick Lau, et al.
Pageof 11